A Broad Phenotypic Screen Identifies Novel Phenotypes Driven by a Single Mutant Allele in Huntington’s Disease CAG Knock-In Mice

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG trinucleotide repeat in the HTT gene encoding huntingtin. The disease has an insidious course, typically progressing over 10-15 years until death. Currently there is no effective disease-modifying therapy. To better understand the HD pathogenic process we have developed genetic HTT CAG knock-in mouse models that accurately recapitulate the HD mutation in man. Here, we describe results of a broad, standardized phenotypic screen in 10-46 week old heterozygous HdhQ111 knock-in mice, probing a wide range of physiological systems. The results of this screen revealed a number of behavioral abnormalities in HdhQ111/+ mice that include hypoactivity, decreased anxiety, motor learning and coordination deficits, and impaired olfactory discrimination. The screen also provided evidence supporting subtle cardiovascular, lung, and plasma metabolite alterations. Importantly, our results reveal that a single mutant HTT allele in the mouse is sufficient to elicit multiple phenotypic abnormalities, consistent with a dominant disease process in patients. These data provide a starting point for further investigation of several organ systems in HD, for the dissection of underlying pathogenic mechanisms and for the identification of reliable phenotypic endpoints for therapeutic testing.

[1]  R. Gold,et al.  Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease , 2013, Neurology.

[2]  Mei Kwan,et al.  Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175 , 2012, PloS one.

[3]  A. Hannan,et al.  Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease , 2012, The Journal of physiology.

[4]  Tongbin Li,et al.  Homeostatic Adaptations in Brain Energy Metabolism in Mouse Models of Huntington Disease , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  S. Dunnett,et al.  Light and electron microscopic characterization of the evolution of cellular pathology in HdhQ92 Huntington's disease knock-in mice , 2012, Brain Research Bulletin.

[6]  S. Dunnett,et al.  Longitudinal analysis of the behavioural phenotype in Hdh (CAG)150 Huntington's disease knock-in mice , 2012, Brain Research Bulletin.

[7]  S. Dunnett,et al.  Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(CAG)150 Huntington's disease knock-in mouse , 2012, Brain Research Bulletin.

[8]  S. Dunnett,et al.  Early onset deficits on the delayed alternation task in the HdhQ92 knock-in mouse model of Huntington's disease , 2012, Brain Research Bulletin.

[9]  S. Dunnett,et al.  Five choice serial reaction time performance in the HdhQ92 mouse model of Huntington's disease , 2012, Brain Research Bulletin.

[10]  S. Dunnett,et al.  Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington's disease knock-in mice , 2012, Brain Research Bulletin.

[11]  Richard L. Doty,et al.  Olfactory dysfunction in Parkinson disease , 2012, Nature Reviews Neurology.

[12]  N. Torquet,et al.  Activation of adult-born neurons facilitates learning and memory , 2012, Nature Neuroscience.

[13]  A. Giralt,et al.  Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. , 2012, Human molecular genetics.

[14]  Jane S. Paulsen,et al.  CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion , 2012, Neurology.

[15]  F. Saudou,et al.  Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation , 2012, Neuroscience Letters.

[16]  M. Štrucl,et al.  Microcirculation response to local cooling in patients with Huntington’s disease , 2012, Journal of Neurology.

[17]  R. Schiffmann,et al.  Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models* , 2011, The Journal of Biological Chemistry.

[18]  C. Colwell,et al.  Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington’s disease. , 2011, PLoS currents.

[19]  E. Cattaneo,et al.  Emerging roles for cholesterol in Huntington's disease , 2011, Trends in Neurosciences.

[20]  T. Gillis,et al.  Quantification of Age-Dependent Somatic CAG Repeat Instability in Hdh CAG Knock-In Mice Reveals Different Expansion Dynamics in Striatum and Liver , 2011, PloS one.

[21]  M. MacDonald,et al.  Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative. , 2011, Human molecular genetics.

[22]  B. Thorens Brain glucose sensing and neural regulation of insulin and glucagon secretion , 2011, Diabetes, obesity & metabolism.

[23]  M. MacDonald,et al.  HD CAG-correlated gene expression changes support a simple dominant gain of function. , 2011, Human molecular genetics.

[24]  L. Lanfumey,et al.  Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression , 2011, PloS one.

[25]  Steve D. M. Brown,et al.  High-throughput mouse phenotyping. , 2011, Methods.

[26]  R. Mandel,et al.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats , 2011, Experimental Neurology.

[27]  R. Barker,et al.  Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls. , 2011, PLoS currents.

[28]  B. Christie,et al.  Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease , 2011, Neurobiology of Disease.

[29]  Donald A. Wilson,et al.  Sniffing out the contributions of the olfactory tubercle to the sense of smell: Hedonics, sensory integration, and more? , 2011, Neuroscience & Biobehavioral Reviews.

[30]  H. Fuchs,et al.  Mouse phenotyping. , 2011, Methods.

[31]  N. Secher,et al.  Reduced gluconeogenesis and lactate clearance in Huntington's disease , 2010, Neurobiology of Disease.

[32]  T. Dick,et al.  Modulation of cardiorespiratory function mediated by the paraventricular nucleus , 2010, Respiratory Physiology & Neurobiology.

[33]  R. Albin,et al.  Early alterations of autophagy in Huntington disease-like mice , 2010, Autophagy.

[34]  Julia Noack,et al.  Different importance of the volatile and non-volatile fractions of an olfactory signature for individual social recognition in rats versus mice and short-term versus long-term memory , 2010, Neurobiology of Learning and Memory.

[35]  J. Marinus,et al.  Autonomic symptoms in patients and pre‐manifest mutation carriers of Huntington’s disease , 2010, European journal of neurology.

[36]  N. Wood,et al.  Disruption of Peripheral Circadian Timekeeping in a Mouse Model of Huntington's Disease and Its Restoration by Temporally Scheduled Feeding , 2010, The Journal of Neuroscience.

[37]  S. Cregan,et al.  Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease , 2010, The Journal of Neuroscience.

[38]  B. Peterlin,et al.  Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease , 2009, Acta neurologica Scandinavica.

[39]  M. MacDonald,et al.  Huntingtin facilitates polycomb repressive complex 2 , 2009, Human molecular genetics.

[40]  W. Brooks,et al.  Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[41]  M. Mehler,et al.  Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease , 2009, Proceedings of the National Academy of Sciences.

[42]  G. Bates,et al.  Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease , 2009, PloS one.

[43]  S. Dunnett,et al.  Rule learning, visuospatial function and motor performance in the HdhQ92 knock-in mouse model of Huntington's disease , 2009, Behavioural Brain Research.

[44]  T. Hansen,et al.  Huntington’s Disease Does Not Appear to Increase the Risk of Diabetes Mellitus , 2009, Journal of neuroendocrinology.

[45]  M. MacDonald,et al.  Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models , 2009, Neurobiology of Disease.

[46]  J. Willey,et al.  PRESTROKE PHYSICAL ACTIVITY IS ASSOCIATED WITH SEVERITY AND LONG-TERM OUTCOME FROM FIRST-EVER STROKE , 2009, Neurology.

[47]  P. Brundin,et al.  Beyond the brain: widespread pathology in Huntington's disease , 2009, The Lancet Neurology.

[48]  M. MacDonald,et al.  Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease* , 2009, The Journal of Biological Chemistry.

[49]  Edith T. Lopez,et al.  Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes , 2009, Neurobiology of Disease.

[50]  Matthew T. Lorincz,et al.  Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells , 2009, Molecular and Cellular Neuroscience.

[51]  W. Brooks,et al.  Bone density and brain atrophy in early Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[52]  H. Fuchs,et al.  Systemic first-line phenotyping. , 2009, Methods in molecular biology.

[53]  Richard Axel,et al.  Mice with a “Monoclonal Nose”: Perturbations in an Olfactory Map Impair Odor Discrimination , 2008, Neuron.

[54]  M. Chesselet,et al.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice , 2008, Neuroscience.

[55]  T. Stijnen,et al.  Weight loss in Huntington disease increases with higher CAG repeat number , 2008, Neurology.

[56]  R. Albin,et al.  Rodent genetic models of Huntington disease , 2008, Neurobiology of Disease.

[57]  J. Cordes,et al.  Cardiovagal modulation upon postural change is altered in Huntington’s disease , 2008, European journal of neurology.

[58]  S. Dunnett,et al.  Time course of choice reaction time deficits in the HdhQ92 knock-in mouse model of Huntington's disease in the operant Serial Implicit Learning Task (SILT) , 2008, Behavioural Brain Research.

[59]  V. Kostic,et al.  Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. , 2008, Archives of neurology.

[60]  T. Shimazaki,et al.  [Mammalian neural stem cells]. , 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[61]  A. Nørremølle,et al.  Impaired Glucose Tolerance in the R6/1 Transgenic Mouse Model of Huntington’s Disease , 2007, Journal of neuroendocrinology.

[62]  Jane S. Paulsen,et al.  Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[63]  Roger L Albin,et al.  Longitudinal Evaluation of the Hdh (CAG)150 Knock-In Murine Model of Huntington's Disease , 2007, The Journal of Neuroscience.

[64]  C. Blakemore,et al.  Olfactory abnormalities in Huntington’s disease: Decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients , 2007, Brain Research.

[65]  Danielle A. Simmons,et al.  Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease , 2007, The Journal of Neuroscience.

[66]  G. Rebec,et al.  Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease , 2007, Behavioural Brain Research.

[67]  K. Hoyt,et al.  Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease , 2007, Neurobiology of Disease.

[68]  Juan Fernandez-Ruiz,et al.  Olfaction and neurodegeneration in HD , 2007, Neuroreport.

[69]  S. Dunnett,et al.  The operant serial implicit learning task reveals early onset motor learning deficits in the HdhQ92 knock‐in mouse model of Huntington's disease , 2007, The European journal of neuroscience.

[70]  N. Aziz,et al.  Hypothalamic Dysfunction and Neuroendocrine and Metabolic Alterations in Huntington Disease: Clinical Consequences and Therapeutic Implications , 2007, Reviews in the neurosciences.

[71]  F. Richer,et al.  Episodic memory impairment in Huntington's disease: A meta-analysis , 2006, Neuropsychologia.

[72]  M. Larsson,et al.  Olfactory Functions in Asymptomatic Carriers of the Huntington Disease Mutation , 2006, Journal of clinical and experimental neuropsychology.

[73]  Samuel Garcia,et al.  Neurogenic correlates of an olfactory discrimination task in the adult olfactory bulb , 2006, The European journal of neuroscience.

[74]  Ronald Wetzel,et al.  Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.

[75]  D. Devanand,et al.  Olfactory dysfunction as a predictor of neurodegenerative disease , 2006, Current neurology and neuroscience reports.

[76]  Edith T. Lopez,et al.  Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. , 2006, Human molecular genetics.

[77]  S. Tabrizi,et al.  Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. , 2006, Human molecular genetics.

[78]  S. Dunnett,et al.  Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease , 2006, Brain Research Bulletin.

[79]  C. Blakemore,et al.  Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment , 2006, The European journal of neuroscience.

[80]  J. Lucas,et al.  Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain , 2006, The European journal of neuroscience.

[81]  P. Brundin,et al.  Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice , 2005, Neurobiology of Disease.

[82]  O. Gavrilova,et al.  Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. , 2005, The Journal of clinical investigation.

[83]  M. MacDonald,et al.  HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. , 2005, Human molecular genetics.

[84]  B Fischl,et al.  Regional cortical thinning in preclinical Huntington disease and its relationship to cognition , 2005, Neurology.

[85]  Werner Müller,et al.  Introducing the German Mouse Clinic: open access platform for standardized phenotyping , 2005, Nature Methods.

[86]  B. Peterlin,et al.  Early sympathetic hyperactivity in Huntington's disease , 2004, European journal of neurology.

[87]  E. Vandenbussche,et al.  Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation , 2004, Journal of Neurology.

[88]  C. Blakemore,et al.  Decreased hippocampal cell proliferation in R6/1 Huntington's mice , 2004, Neuroreport.

[89]  J R Hodges,et al.  Profile of cognitive progression in early Huntington’s disease , 2003, Neurology.

[90]  M. Chesselet,et al.  Time course of early motor and neuropathological anomalies in a knock‐in mouse model of Huntington's disease with 140 CAG repeats , 2003, The Journal of comparative neurology.

[91]  M. MacDonald,et al.  Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. , 2003, Human molecular genetics.

[92]  J. Mysore,et al.  Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice. , 2002, Human molecular genetics.

[93]  H. Przuntek,et al.  Autonomic nervous system function in Huntington's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[94]  M. MacDonald,et al.  Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. , 2002, Human molecular genetics.

[95]  R. Albin,et al.  Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.

[96]  B. Gulyás,et al.  Olfactory Functions Are Mediated by Parallel and Hierarchical Processing , 2000, Neuron.

[97]  M. MacDonald,et al.  Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. , 2000, Human molecular genetics.

[98]  J. Vincent,et al.  Importance of newly generated neurons in the adult olfactory bulb for odor discrimination. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Jane S. Paulsen,et al.  Odor detection, learning, and memory in Huntington's disease , 1999, Journal of the International Neuropsychological Society.

[100]  J. Romano,et al.  Sympathetic skin response and heart rate variability in patients with Huntington disease. , 1999, Archives of neurology.

[101]  Harper Ps Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders. , 1999 .

[102]  S. W. Davies,et al.  Formation of polyglutamine inclusions in non-CNS tissue. , 1999, Human molecular genetics.

[103]  H. Johnston,et al.  A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. , 1999, Human molecular genetics.

[104]  M. Hurlbert,et al.  Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. , 1999, Diabetes.

[105]  P. Harper Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[106]  Jacqueline K. White,et al.  Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. , 1999, Human molecular genetics.

[107]  S. File,et al.  Striking changes in anxiety in Huntington's disease transgenic mice , 1998, Brain Research.

[108]  Jacqueline K. White,et al.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion , 1997, Nature Genetics.

[109]  P. Brennan,et al.  NEURAL MECHANISMS OF MAMMALIAN OLFACTORY LEARNING , 1997, Progress in Neurobiology.

[110]  P. Moberg,et al.  Odor identification in Huntington's disease patients and asymptomatic gene carriers. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[111]  T. Robbins,et al.  Executive and mnemonic functions in early Huntington's disease. , 1996, Brain : a journal of neurology.

[112]  E. Benarroch The central autonomic network: functional organization, dysfunction, and perspective. , 1993, Mayo Clinic proceedings.

[113]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[114]  D. Lanska,et al.  Huntington's disease mortality in the United States , 1988, Neurology.

[115]  L. Farrer Diabetes mellitus in Huntington disease , 1985, Clinical genetics.

[116]  E. Chiu,et al.  Causes of death in Huntington's Disease , 1982, The Medical journal of Australia.

[117]  S. Podolsky,et al.  Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. , 1977, Gerontology.

[118]  Shirley Hansen,et al.  Huntington's Chorea , 1973 .

[119]  J. Bolt,et al.  Huntington's chorea. A study of liver function and histology. , 1973, The Quarterly journal of medicine.